|Kristin Hodous||Investor Relations|
|Jeff Albers||Chief Executive Officer|
|Andy Boral||Chief Medical Officer|
|Mike Landsittel||Vice President, Finance|
|Marion Dorsch||Chief Scientific Officer|
|Terence Flynn||Goldman Sachs|
|Eric Schmidt||Cowen and Company|
|Sarah Frank||Raymond James|
|Mike King||JMP Securities|
Good day, ladies and gentlemen, and welcome to the Q3 2017 Blueprint Medicines Corp. Earnings Conference Call. [Operator Instructions] As a reminder, this conference maybe recorded. I would like to introduce your host for today's conference, Kristin Hodous.
You may begin.